Sol Gel Company Leadership

SLGL Stock  USD 73.80  6.60  9.82%   
Sol Gel's insiders are aggressively buying. The analysis of insiders' sentiment of trading Sol Gel Technologies stock suggests that most insiders are extremely bullish at this time. Sol Gel employs about 34 people. The company is managed by 9 executives with a total tenure of roughly 29 years, averaging almost 3.0 years of service per executive, having 3.78 employees per reported executive.
Alon SeriLevy  CEO
CEO, Co-Founder, Director
Itzik Yosef  President
Vice President - Operations

Insider Sentiment 100

 Aggressively Buying

 
Selling
 
Buying

Latest Trades

2026-01-27Opaleye Management Inc.Acquired 100 @ 57.05View
2026-01-23Opaleye Management Inc.Acquired 1151 @ 55.98View
2026-01-22Opaleye Management Inc.Acquired 2173 @ 56.57View
2025-12-31Opaleye Management Inc.Acquired 22497 @ 41.99View
2025-12-30Opaleye Management Inc.Acquired 35169 @ 41.99View
2025-12-29Opaleye Management Inc.Acquired 8638 @ 41.85View
2025-12-26Opaleye Management Inc.Acquired 1626 @ 41.68View
2025-12-23Opaleye Management Inc.Acquired 260 @ 41.66View
2025-12-22Opaleye Management Inc.Acquired 1019 @ 41.15View
2025-12-17Opaleye Management Inc.Acquired 2735 @ 40.37View
2025-12-03Opaleye Management Inc.Acquired 2524 @ 37.81View
2025-12-01Opaleye Management Inc.Acquired 4340 @ 37.37View
Monitoring Sol Gel's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sol Gel Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

Sol Gel's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Sol Gel's future performance. Based on our forecasts, it is anticipated that Sol will maintain a workforce of about 50 employees by March 2026.
 
Covid
 
Interest Hikes

Sol Gel Management Team Effectiveness

The company has return on total asset (ROA) of (0.0733) % which means that it has lost $0.0733 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1021) %, meaning that it created substantial loss on money invested by shareholders. Sol Gel's management efficiency ratios could be used to measure how well Sol Gel manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.28. Return On Capital Employed is expected to rise to -0.43 this year. At this time, Sol Gel's Fixed Asset Turnover is quite stable compared to the past year. Asset Turnover is expected to rise to 0.30 this year, although the value of Other Assets will most likely fall to 1.09.
The value of Common Stock Shares Outstanding is expected to slide to about 20.6 M. The value of Net Loss is expected to slide to about (14.1 M)The market capitalization of Sol Gel is $99.1 Million. Sol Gel Technologies has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 70.0 % of Sol Gel outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.
 
Shares in Circulation  
First Issued
2016-03-31
Previous Quarter
2.8 M
Current Value
2.8 M
Avarage Shares Outstanding
19.4 M
Quarterly Volatility
7.4 M
 
Yuan Drop
 
Covid
 
Interest Hikes
Some institutional investors establish a significant position in stocks such as Sol Gel in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Sol Gel, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Sol Gel Workforce Comparison

Sol Gel Technologies is rated fifth in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 833. Sol Gel holds roughly 34.0 in number of employees claiming about 4% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.14) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.65 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.65.

Sol Gel Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Sol Gel insiders, such as employees or executives, is commonly permitted as long as it does not rely on Sol Gel's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Sol Gel insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Sol Gel Notable Stakeholders

A Sol Gel stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Sol Gel often face trade-offs trying to please all of them. Sol Gel's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Sol Gel's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Alon SeriLevyCEO, Co-Founder, DirectorProfile
Moshe ArkinInterim ChairmanProfile
Itzik YosefVice President - OperationsProfile
Karine NeimannVice President - Projects and Planning, Chief ChemistProfile
Tamar JutkowitzVP CounselProfile
Gilad MamlokChief OfficerProfile
Michael GlezinChief OfficerProfile
Pr AvnirCoFounderProfile
Eyal BenOrChief OfficerProfile
String symbol = request.getParameter("s");

About Sol Gel Management Performance

The success or failure of an entity such as Sol Gel Technologies often depends on how effective the management is. Sol Gel management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Sol management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Sol management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.27)(0.28)
Return On Capital Employed(0.45)(0.43)
Return On Assets(0.27)(0.28)
Return On Equity(0.42)(0.40)

Sol Gel Workforce Analysis

Traditionally, organizations such as Sol Gel use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Sol Gel within its industry.

Sol Gel Manpower Efficiency

Return on Sol Gel Manpower

Revenue Per Employee339.4K
Revenue Per Executive1.3M
Net Loss Per Employee311.2K
Net Loss Per Executive1.2M
Working Capital Per Employee765K
Working Capital Per Executive2.9M
When determining whether Sol Gel Technologies is a strong investment it is important to analyze Sol Gel's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Sol Gel's future performance. For an informed investment choice regarding Sol Stock, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sol Gel Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sol Gel. If investors know Sol will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Sol Gel assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth
4.876
Earnings Share
(1.22)
Revenue Per Share
8.59
Quarterly Revenue Growth
2.177
Return On Assets
(0.07)
Investors evaluate Sol Gel Technologies using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Sol Gel's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Sol Gel's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Sol Gel's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sol Gel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Sol Gel's market price signifies the transaction level at which participants voluntarily complete trades.